Role of Talmakhana Amrita kwath in Vatarakta WSR to Gouty Arthritis

A Clinical study on the efficacy of Talmakhana Amrita kwath in Vatarakta W.S.R to Gouty Arthritis.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/03/050484

Enrollment

Registered

2023-03-09

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M049- Autoinflammatory syndrome, unspecified Health Condition 2: M109- Gout, unspecified Health Condition 3: M109- Gout, unspecified Health Condition 4: M109- Gout, unspecified Health Condition 5: M109- Gout, unspecified Health Condition 6: M109- Gout, unspecified Health Condition 7: M048- Other autoinflammatory syndromes

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient having the clinical feature of vatarakta. 2.Patient having chronicity of vatarakta less than one year. 3.Patient willing to give consent for trial with firm residential address andf contact.

Exclusion criteria

Exclusion criteria: 1.Age below 20 and above 60 2.Patient suffering from uncontrolled Diabetes,Hypertension,TB,AIDS.

Design outcomes

Primary

Measure	Time frame
releif in (1)joint pain (2) inflammation (3) tenderness (4) rednessTimepoint: 14th,21th,35th and 42nd days	—

Secondary

Measure	Time frame
releif in (1)burning sensation (2)Tophi (3)numbness (4)itchingTimepoint: 14th,21th,35th and 42nd days	—

Countries

India

Contacts

Public ContactDr Vijay Bahadur Singh

Government Ayurvedic College Patna

vijay.md09@gmail.com7004642738

Outcome results